Greenwood Gearhart Inc. Sells 156 Shares of Stryker Co. (NYSE:SYK) – Riverton Roll

Greenwood Gearhart Inc. lowered its stake in Stryker Co. (NYSE:SYK) by 0.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,673 shares of the medical technology companys stock after selling 156 shares during the period. Greenwood Gearhart Inc.s holdings in Stryker were worth $5,810,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of SYK. State Street Corp boosted its holdings in Stryker by 1.7% during the 3rd quarter. State Street Corp now owns 13,462,431 shares of the medical technology companys stock valued at $2,918,870,000 after acquiring an additional 229,189 shares during the period. California Public Employees Retirement System increased its stake in shares of Stryker by 2.6% during the fourth quarter. California Public Employees Retirement System now owns 1,381,527 shares of the medical technology companys stock valued at $290,038,000 after buying an additional 34,560 shares during the period. Sumitomo Mitsui Trust Holdings Inc. increased its stake in shares of Stryker by 1.4% during the fourth quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,333,479 shares of the medical technology companys stock valued at $279,951,000 after buying an additional 19,021 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA increased its stake in shares of Stryker by 0.6% during the fourth quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 1,272,877 shares of the medical technology companys stock valued at $267,228,000 after buying an additional 8,047 shares during the period. Finally, Parametric Portfolio Associates LLC raised its holdings in shares of Stryker by 2.3% in the third quarter. Parametric Portfolio Associates LLC now owns 1,027,882 shares of the medical technology companys stock valued at $222,331,000 after acquiring an additional 22,698 shares in the last quarter. 73.29% of the stock is currently owned by institutional investors.

In related news, COO Timothy J. Scannell sold 4,666 shares of Stryker stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $206.28, for a total transaction of $962,502.48. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 7.20% of the companys stock.

A number of analysts recently weighed in on SYK shares. Cantor Fitzgerald reaffirmed a neutral rating on shares of Stryker in a research note on Wednesday, January 29th. Evercore ISI upgraded shares of Stryker from an in-line rating to an outperform rating in a report on Thursday, January 2nd. Barclays cut shares of Stryker from an overweight rating to an equal weight rating and lowered their price target for the stock from $226.00 to $207.00 in a research report on Tuesday, November 5th. BTIG Research reissued a buy rating on shares of Stryker in a report on Thursday, January 30th. Finally, Robert W. Baird lifted their price objective on shares of Stryker from $242.00 to $248.00 and gave the company an outperform rating in a report on Wednesday, January 29th. Seven equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. The stock currently has a consensus rating of Buy and an average price target of $227.45.

Shares of Stryker stock opened at $214.08 on Tuesday. The company has a quick ratio of 1.84, a current ratio of 2.58 and a debt-to-equity ratio of 0.80. Stryker Co. has a twelve month low of $174.84 and a twelve month high of $223.45. The business has a 50-day moving average price of $210.80 and a 200 day moving average price of $211.57. The firm has a market cap of $78.82 billion, a PE ratio of 39.07, a P/E/G ratio of 2.33 and a beta of 0.74.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Tuesday, January 28th. The medical technology company reported $2.49 earnings per share (EPS) for the quarter, topping the Thomson Reuters consensus estimate of $2.46 by $0.03. Stryker had a return on equity of 25.75% and a net margin of 13.99%. The company had revenue of $4.13 billion for the quarter, compared to analysts expectations of $4.11 billion. During the same period in the previous year, the firm posted $2.18 EPS. Strykers revenue was up 8.8% compared to the same quarter last year. On average, sell-side analysts expect that Stryker Co. will post 9.1 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Tuesday, December 31st were given a dividend of $0.575 per share. This is an increase from Strykers previous quarterly dividend of $0.52. The ex-dividend date was Monday, December 30th. This represents a $2.30 dividend on an annualized basis and a yield of 1.07%. Strykers dividend payout ratio (DPR) is presently 27.85%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

Greenwood Gearhart Inc. Sells 156 Shares of Stryker Co. (NYSE:SYK) – Riverton Roll

Categories

Archives